Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 467

1.

Novel cardiovascular risk biomarkers in metabolic syndrome.

Montecucco F, Liberale L, Carbone F.

Biomark Med. 2019 Oct 10. doi: 10.2217/bmm-2019-0366. [Epub ahead of print] No abstract available.

PMID:
31599166
2.

Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10.

Moccia M, Capacchione A, Lanzillo R, Carbone F, Micillo T, Matarese G, Palladino R, Brescia Morra V.

Brain Sci. 2019 Sep 27;9(10). pii: E259. doi: 10.3390/brainsci9100259.

3.

Correction: Identification of miRNAs involved in fruit ripening by deep sequencing of Olea europaea L. transcriptome.

Carbone F, Bruno L, Perrotta G, Bitonti MB, Muzzalupo I, Chiappetta A.

PLoS One. 2019 Sep 30;14(9):e0223354. doi: 10.1371/journal.pone.0223354. eCollection 2019.

4.

Platelet-to-lymphocyte ratio at the time of carotid endarterectomy is associated with acute coronary syndrome occurrence.

Bonaventura A, Carbone F, Liberale L, Mach F, Roth A, Burger F, Pende A, Vecchié A, Bertolotto M, Spinella G, Pane B, Palombo D, Dallegri F, Montecucco F.

J Cardiovasc Med (Hagerstown). 2019 Sep 20. doi: 10.2459/JCM.0000000000000869. [Epub ahead of print]

PMID:
31567635
5.

Drugs under development for the treatment of functional dyspepsia and related disorders.

Tack J, Masuy I, Van Den Houte K, Wauters L, Schol J, Vanuytsel T, Vandenberghe A, Carbone F.

Expert Opin Investig Drugs. 2019 Oct 8:1-19. doi: 10.1080/13543784.2019.1673365. [Epub ahead of print]

PMID:
31566013
6.

Impact of Incidental Findings During the Evaluation of Live Kidney Donors on Post-Transplant Outcomes: A Single Center Analysis.

De Marco E, Corona D, Origlio F, Giuffrida G, Gioco R, Palermo C, Privitera F, Giaquinta A, Ilari A, D'Errico S, Pinto F, Carbone F, Carbonaro A, Veroux P, Veroux M.

Transplant Proc. 2019 Sep 19. pii: S0041-1345(19)30633-5. doi: 10.1016/j.transproceed.2019.04.097. [Epub ahead of print]

PMID:
31543275
7.

Research update for articles published in EJCI in 2017.

Arellano-Orden E, Bacopoulou F, Baicus C, Bonfrate L, Broadbent J, Buechler C, Carbone F, Charmandari E, Davis GR, Dullaart RPF, Efthymiou V, Goeser F, Goswami N, Jong GP, Lichtenauer M, Liou YS, Lutz P, Maeng M, Mert GÖ, Mert KU, Montecucco F, Ndrepepa G, Olesen KKW, Oliveira P, Perton FG, Portincasa P, Rodriguez-Panadero F, Schernthaner C, Schutte R.

Eur J Clin Invest. 2019 Oct;49(10):e13163. doi: 10.1111/eci.13163. Epub 2019 Sep 16. No abstract available.

PMID:
31524285
8.

Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations.

Carbone F, Djamshidian A, Seppi K, Poewe W.

CNS Drugs. 2019 Sep;33(9):905-918. doi: 10.1007/s40263-019-00661-z. Review.

PMID:
31473980
9.

Opioids in Gastroparesis: Bystander or Cause?

Pannemans J, Schol J, Goelen N, Masuy I, van den Houte K, Carbone F, Basnayake C, Tack J.

Clin Gastroenterol Hepatol. 2019 Aug 27. pii: S1542-3565(19)30915-2. doi: 10.1016/j.cgh.2019.08.040. [Epub ahead of print] No abstract available.

PMID:
31470177
10.

The Therapeutic Potential of Nanoparticles to Reduce Inflammation in Atherosclerosis.

Gorabi AM, Kiaie N, Reiner Ž, Carbone F, Montecucco F, Sahebkar A.

Biomolecules. 2019 Aug 26;9(9). pii: E416. doi: 10.3390/biom9090416. Review.

11.

Duodenal nutrient exposure contributes to enhancing gastric accommodation.

Carbone F, Verschueren S, Rotondo A, Tack J.

Neurogastroenterol Motil. 2019 Aug 26:e13697. doi: 10.1111/nmo.13697. [Epub ahead of print]

PMID:
31448521
12.

Identification of miRNAs involved in fruit ripening by deep sequencing of Olea europaea L. transcriptome.

Carbone F, Bruno L, Perrotta G, Bitonti MB, Muzzalupo I, Chiappetta A.

PLoS One. 2019 Aug 22;14(8):e0221460. doi: 10.1371/journal.pone.0221460. eCollection 2019. Erratum in: PLoS One. 2019 Sep 30;14(9):e0223354.

13.

Analysis of Postprandial Symptom Patterns in Subgroups of Patients With Rome III or Rome IV Functional Dyspepsia.

Carbone F, Vanuytsel T, Tack J.

Clin Gastroenterol Hepatol. 2019 Aug 5. pii: S1542-3565(19)30842-0. doi: 10.1016/j.cgh.2019.07.053. [Epub ahead of print]

PMID:
31394286
14.

Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer.

Carbone F, Grossi F, Bonaventura A, Vecchié A, Minetti S, Bardi N, Elia E, Ansaldo AM, Ferrara D, Rijavec E, Dal Bello MG, Biello F, Rossi G, Tagliamento M, Alama A, Coco S, Spallarossa P, Dallegri F, Genova C, Montecucco F.

Clin Exp Metastasis. 2019 Oct;36(5):449-456. doi: 10.1007/s10585-019-09984-z. Epub 2019 Aug 2.

PMID:
31376097
15.

Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study.

Bonaventura A, Grossi F, Carbone F, Vecchié A, Minetti S, Bardi N, Elia E, Ansaldo AM, Ferrara D, Rijavec E, Dal Bello MG, Rossi G, Biello F, Tagliamento M, Alama A, Coco S, Spallarossa P, Dallegri F, Genova C, Montecucco F.

Cancer Immunol Immunother. 2019 Aug;68(8):1351-1358. doi: 10.1007/s00262-019-02367-z. Epub 2019 Jul 20.

PMID:
31327024
16.

Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study.

Carbone F, Van den Houte K, Clevers E, Andrews CN, Papathanasopoulos A, Holvoet L, Van Oudenhove L, Caenepeel P, Arts J, Vanuytsel T, Tack J.

Am J Gastroenterol. 2019 Aug;114(8):1265-1274. doi: 10.14309/ajg.0000000000000304.

PMID:
31295161
17.

Challenges in reducing atherosclerotic inflammation in patients with familial hypercholesterolemia.

Montecucco F, Carbone F, Liberale L, Sahebkar A.

Eur J Prev Cardiol. 2019 Jul 9:2047487319862907. doi: 10.1177/2047487319862907. [Epub ahead of print] No abstract available.

PMID:
31288540
18.

Should I stay or should I go-Reconciling clashing perspectives on CD4+ tissue-resident memory T cells.

Carbone FR, Gebhardt T.

Sci Immunol. 2019 Jul 5;4(37). pii: eaax5595. doi: 10.1126/sciimmunol.aax5595. Review.

PMID:
31278121
19.

Adipose Tissue Composition in Obesity and After Bariatric Surgery.

Adami GF, Carbone F, Montecucco F, Camerini G, Cordera R.

Obes Surg. 2019 Sep;29(9):3030-3038. doi: 10.1007/s11695-019-04030-z. Review.

PMID:
31190263
20.

Obesity worsens central inflammation and disability in multiple sclerosis.

Stampanoni Bassi M, Iezzi E, Buttari F, Gilio L, Simonelli I, Carbone F, Micillo T, De Rosa V, Sica F, Furlan R, Finardi A, Fantozzi R, Storto M, Bellantonio P, Pirollo P, Di Lemme S, Musella A, Mandolesi G, Centonze D, Matarese G.

Mult Scler. 2019 Jun 4:1352458519853473. doi: 10.1177/1352458519853473. [Epub ahead of print]

PMID:
31161863

Supplemental Content

Loading ...
Support Center